NRX Pharmaceuticals (NRXP) EPS (Diluted) Growth (1y) (2021 - 2026)
NRX Pharmaceuticals (NRXP) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,091.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | -29.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.33% |
| Dec 31, 2025 | -90.28% |
| Sep 30, 2025 | -39.48% |
| Jun 30, 2025 | 47.07% |
| Mar 31, 2025 | 39.43% |
| Dec 31, 2024 | 49.06% |
| Sep 30, 2024 | 54.84% |
| Jun 30, 2024 | 27.98% |
| Mar 31, 2024 | -21.88% |
| Dec 31, 2023 | 65.42% |
| Sep 30, 2023 | 44.75% |
| Jun 30, 2023 | -4.01% |
| Mar 31, 2023 | 77.59% |
| Dec 31, 2022 | 75.97% |
| Sep 30, 2022 | 81.17% |
| Jun 30, 2022 | 98.27% |
| Mar 31, 2022 | -947.23% |
| Dec 31, 2021 | 50.78% |
| Sep 30, 2021 | -380.00% |
| Jun 30, 2021 | -219,909.07% |